Medical castration with LHRH agonists is a significant trend in the treatment of locally advanced and metastatic prostate cancer (PC). The article is devoted to the effectiveness of synthetic LHRH agonist buserelin (Buserelin-depo) in the treatment of patients with hormone dependent PC. Administration of Buserelin-depot results in a decrease of the prostate-specific antigen levels. st... https://www.roneverhart.com/SPMX50003S50H5-Spektrum-RC-3S-Smart-LiPo-Hard-Case-50C-Battery-Pack-w-IC5-Connector-11-1V-5000mAh/